54108-84-8Relevant articles and documents
COMPOSITIONS AND METHODS FOR IMMUNE MODULATION AND TREATMENT OF CANCER
-
Paragraph 0245; 0246, (2020/07/31)
The disclosure relates to rexinoids, including compounds of the Formula (I) and (II) or a pharmaceutically acceptable salt, polymorph, prodrug, solvate or clathrate thereof. These rexinoids are useful for increasing PD-L1 in vivo, for treatment of cancer, and for inhibiting the onset of cancer.